PL364746A1 - Cykloheksylo (alkilo) propanoloaminy, sposób ich wytwarzania i zawierające je środki farmaceutyczne - Google Patents

Cykloheksylo (alkilo) propanoloaminy, sposób ich wytwarzania i zawierające je środki farmaceutyczne

Info

Publication number
PL364746A1
PL364746A1 PL01364746A PL36474601A PL364746A1 PL 364746 A1 PL364746 A1 PL 364746A1 PL 01364746 A PL01364746 A PL 01364746A PL 36474601 A PL36474601 A PL 36474601A PL 364746 A1 PL364746 A1 PL 364746A1
Authority
PL
Poland
Prior art keywords
propanolamines
cyclohexyl
alkyl
preparation
pharmaceutical compositions
Prior art date
Application number
PL01364746A
Other languages
English (en)
Other versions
PL206695B1 (pl
Inventor
Philippe R. Bovy
Roberto Cecchi
Gilles Courtemanche
Ambrogio Oliva
Nunzia Viviani
Tiziano Croci
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of PL364746A1 publication Critical patent/PL364746A1/pl
Publication of PL206695B1 publication Critical patent/PL206695B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
PL364746A 2000-11-30 2001-11-30 Cykloheksylo(alkilo)propanoloaminy, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie PL206695B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0015477A FR2817257B1 (fr) 2000-11-30 2000-11-30 Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
PCT/FR2001/003784 WO2002044139A1 (fr) 2000-11-30 2001-11-30 Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant

Publications (2)

Publication Number Publication Date
PL364746A1 true PL364746A1 (pl) 2004-12-13
PL206695B1 PL206695B1 (pl) 2010-09-30

Family

ID=8857054

Family Applications (1)

Application Number Title Priority Date Filing Date
PL364746A PL206695B1 (pl) 2000-11-30 2001-11-30 Cykloheksylo(alkilo)propanoloaminy, sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie

Country Status (24)

Country Link
US (3) US7388031B2 (pl)
EP (1) EP1341753B1 (pl)
JP (1) JP4024149B2 (pl)
CN (2) CN1283622C (pl)
AR (1) AR031438A1 (pl)
AT (1) ATE374177T1 (pl)
AU (2) AU2002222079B2 (pl)
BR (1) BR0115768A (pl)
CA (1) CA2429267C (pl)
CY (1) CY1106997T1 (pl)
CZ (1) CZ305140B6 (pl)
DE (1) DE60130676T2 (pl)
DK (1) DK1341753T3 (pl)
ES (1) ES2290201T3 (pl)
FR (1) FR2817257B1 (pl)
HU (1) HU229583B1 (pl)
ME (1) MEP23308A (pl)
MX (1) MXPA03004884A (pl)
PL (1) PL206695B1 (pl)
PT (1) PT1341753E (pl)
RS (1) RS51571B (pl)
SI (1) SI1341753T1 (pl)
SK (1) SK287551B6 (pl)
WO (1) WO2002044139A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
FR2840301B1 (fr) * 2002-05-29 2007-03-23 Sanofi Synthelabo Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique
FR2840304B1 (fr) * 2002-05-29 2007-05-18 Sanofi Synthelabo Derives d'oxophenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique
EP2011490A1 (en) * 2007-07-05 2009-01-07 Sanofi-Aventis Beta adrenergic receptor ligand derivatives for modulating apoptosis
FR2935141B1 (fr) * 2008-08-21 2010-10-08 Sanofi Aventis Procede de preparation de l'ester ethylique de l'acide 4-[trans-4-[(phenylmethyl)-amino]cyclohexyl]benzoique et de son sel hemifumarate
CN102316732B (zh) * 2008-10-31 2015-04-01 梅迪维新技术公司 氮杂*并[4,5-b]吲哚以及使用方法
CN116143575B (zh) * 2023-04-21 2023-06-30 研峰(天津)科学技术应用研究有限公司 昆虫信息素原料3-环己基-1-丙炔合成方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004028A (en) * 1975-08-06 1977-01-18 Smithkline Corporation Phenoxypropanolamines
ATE117980T1 (de) * 1988-06-03 1995-02-15 Lilly Co Eli Serotonin-antagonisten.
US5096908A (en) 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5158956A (en) 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
US5258379A (en) 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5340838A (en) 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL107611A0 (en) 1992-11-18 1994-02-27 Smithkline Beecham Corp Steroid compounds and pharmaceutical compositions containing them
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
IL110857A0 (en) 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
CA2134038C (en) 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
US5776959A (en) 1995-06-05 1998-07-07 Washington University Anticonvulsant and anxiolytic lactam and thiolactam derivatives
ES2158996T3 (es) * 1995-09-21 2001-09-16 Lilly Co Eli Agonistas beta3 adrenergicos selectivos.
EP0792649A1 (en) 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders
US5958429A (en) 1996-08-16 1999-09-28 Eli Lilly And Company Potentiation of serotonin response
FR2755439B1 (fr) 1996-11-05 1998-12-24 Virbac Sa Derives aryloxypropanolamines, leur procede de preparation et leurs applications
US20020019440A1 (en) * 1996-11-05 2002-02-14 Virbac Sa Aryloxypropanolamine derivatives, method of preparation and applications thereof
FR2758460B1 (fr) * 1997-01-21 1999-12-31 Sanofi Sa Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
US5776969A (en) 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
FR2780057B1 (fr) * 1998-06-18 2002-09-13 Sanofi Sa Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
JP2000086603A (ja) 1998-07-15 2000-03-28 Yoshitomi Pharmaceut Ind Ltd 桂皮酸アミド誘導体および３―フェニルプロピオン酸アミド誘導体
AU2400300A (en) 1998-12-30 2000-07-31 Eli Lilly And Company Solution phase synthesis of compounds including amine alcohol functionality
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
US20020019940A1 (en) * 2000-06-16 2002-02-14 Matteson Craig S. Method and apparatus for assigning test and assessment instruments to users
AUPQ841300A0 (en) * 2000-06-27 2000-07-20 Fujisawa Pharmaceutical Co., Ltd. New aminoalcohol derivatives
HUP0301329A2 (hu) 2000-07-13 2003-08-28 Eli Lilly And Co. Béta3 Adrenergiás agonisták, valamint ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás e vegyületek előállítására
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
US6693125B2 (en) 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
FR2840304B1 (fr) * 2002-05-29 2007-05-18 Sanofi Synthelabo Derives d'oxophenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique
FR2840301B1 (fr) 2002-05-29 2007-03-23 Sanofi Synthelabo Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique
WO2004006849A2 (en) 2002-07-15 2004-01-22 Combinatorx, Incorporated Combinations of drugs for the treatment of neoplasms
AU2003262947A1 (en) 2002-08-30 2004-03-19 Pharmacia And Upjohn Company Method of preventing or treating atherosclerosis or restenosis
DE602004017703D1 (de) 2003-02-24 2008-12-24 Arena Pharm Inc Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus
CA2558034A1 (en) 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamine aspartyl protease inhibitors

Also Published As

Publication number Publication date
DE60130676T2 (de) 2008-07-17
YU41703A (sh) 2006-05-25
FR2817257A1 (fr) 2002-05-31
RS51571B (sr) 2011-08-31
PL206695B1 (pl) 2010-09-30
SK287551B6 (sk) 2011-01-04
FR2817257B1 (fr) 2009-03-20
AU2207902A (en) 2002-06-11
US7718646B2 (en) 2010-05-18
DE60130676D1 (de) 2007-11-08
US20080261949A1 (en) 2008-10-23
JP2004514708A (ja) 2004-05-20
MXPA03004884A (es) 2004-05-04
AU2002222079B2 (en) 2006-12-14
ATE374177T1 (de) 2007-10-15
HU229583B1 (en) 2014-02-28
WO2002044139A1 (fr) 2002-06-06
US20070015745A1 (en) 2007-01-18
CZ305140B6 (cs) 2015-05-20
US20040053916A1 (en) 2004-03-18
HK1055945A1 (zh) 2004-01-30
HUP0400565A3 (en) 2004-08-30
SI1341753T1 (sl) 2007-12-31
US7388031B2 (en) 2008-06-17
AR031438A1 (es) 2003-09-24
EP1341753B1 (fr) 2007-09-26
EP1341753A1 (fr) 2003-09-10
JP4024149B2 (ja) 2007-12-19
SK6522003A3 (en) 2003-11-04
US7419974B2 (en) 2008-09-02
MEP23308A (en) 2010-06-10
CA2429267A1 (fr) 2002-06-06
CA2429267C (fr) 2010-09-28
CN1283622C (zh) 2006-11-08
CN1478074A (zh) 2004-02-25
CN1935787A (zh) 2007-03-28
PT1341753E (pt) 2007-11-13
CY1106997T1 (el) 2012-01-25
ES2290201T3 (es) 2008-02-16
DK1341753T3 (da) 2008-01-14
CZ20031499A3 (cs) 2003-08-13
HUP0400565A2 (hu) 2004-06-28
BR0115768A (pt) 2003-12-30

Similar Documents

Publication Publication Date Title
DZ3311A1 (fr) Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation
IL150539A0 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0301281A3 (en) New pharmaceutical composition
HUP0300755A3 (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
HUP0303118A3 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0400926A3 (en) Lipid lowering new biphenylcarboxamides, process for their preparation and pharmaceutical compositions containing them
PL356911A1 (pl) Skondensowane związki azolowe i ich stosowanie jako środki hipoglikemiczne
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0204394A3 (en) Tetrahydropyridines, process for their preparation, pharmaceutical compositions containing them and use thereof
AU3560601A (en) Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
PL360090A1 (pl) Nowe związki aminotriazolonu, proces ich otrzymywania oraz zawierające je kompozycje farmaceutyczne
HU229583B1 (en) Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
AU2002222079A1 (en) Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
AU4834101A (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
HUP0401038A3 (en) Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them
HUP0303688A3 (en) Propanolaminotetralines, preparation thereof and pharmaceutical compositions containing same
IL135707A0 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
HUP0401597A3 (en) Methylene-4-azasteroids, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RECP Rectifications of patent specification